At least two more journals are fighting decisions by Clarivate — the company behind the Impact Factor — to suppress them from the 2019 list of journals assigned a metric that many rightly or wrongly consider career-making.
In a letter to the editorial board of Body Image, an Elsevier journal that was one of 33 suppressed by Clarivate for excessive self-citation, editor in chief Tracy Tylka and nine journal colleagues write:
We are stunned, very confused, and think that this decision is unfair. Implicit in the decision to suppress the journal’s impact factor is the suggestion that editors have attempted to ‘game’ the system (e.g., by soliciting self-citations, preferentially accepting submissions with high self-citations, etc.). We share Clarivate’s view that such practices are unethical, but completely reject any suggestion that we have engaged in gaming the journal’s impact factor.
The editors acknowledge that the self-citation percentages seem high at first glance, but explain:
In 2015, our self-citation percentage (i.e., number of self-citations divided by total number of self-and other-citations) was 32.75%, in 2016 it was 40.4%, in 2017 it was 33.45%, and in 2018 it was 30.5%. These percentages were never flagged, and neither Tom [Cash, the founder of the journal] nor I were ever sent an “editor expression of concern” letter. This year, it was 50.4%.
While these percentages, especially 2019, seem high and alarming, it is important to put them into perspective. We calculated the number of self-citations, on average, that would need to appear in an article to reach a 30%, 40%, and 50% self-citation rate (assuming a fixed number of other-citations). To reach 30%, each article would only need to include 2 self-citations on average, to reach 40%, each article would only need to include 3 self-citations on average, and to reach 50%, each article would only need to include 4 self-citations on average. (Please note that these are estimates based on last year’s other-citations, as we are still awaiting the data to determine the exact number of self- and other-citations we had from 2019). In a reference list including 40-60 citations, 4 is only 6-10%.
Body Image’s editors say they “will publicly push back against Clarivate” because they
are very uneasy about a private, for-profit company like Clarivate setting itself up as a self-appointed and unaccountable judge. While Elsevier is looking into setting up a coordinated response of their journals that were suppressed (a total of 9), we will also contact Clarivate directly, as well as Retraction Watch.
‘A direct impact on patient management’
The International Committee on Systematics of Prokaryotes and the Microbiology Society, publishers of the International Journal of Systematic and Evolutionary Microbiology, made a similar move. The journal posted a letter on their site that Tasha Mellins-Cohen, Director of Technology and Innovation at the Microbiology Society, had sent to Clarivate appealing the company’s decision. Mellins-Cohen writes that:
…we believe the suppression to be unreasonable and to request Clarivate reinstate IJSEM in the JCR as a matter of urgency.
Like Zootaxa, another taxonomy journal suppressed from Clarivate’s list that is also appealing the decision, self-citation in the field is to be expected, Mellins-Cohen explains:
While IJSEM serves the wider microbiological community and in theory all references to the strains validly published in IJSEM should be cited by researchers working on those strains, there is a very peculiar convention among microbiologists who are not taxonomists which leads them not to cite the taxonomic papers in which their research subject was first described. This convention means that, despite taxonomy being critical to the discipline of microbiology, few articles in other journals will cite taxonomic papers. The primary audience of IJSEM is thus taxonomists, and these are the researchers citing IJSEM. This means taxonomic papers are heavily cited in major reference works such as Bergey’s Manual of Systematics of Archaea and Bacteria (BMSAB, described below). The exclusion of citations from Bergey’s to IJSEM in 2019 has artificially raised the self-citation rate in your dataset. The inclusion of Bergey’s, among other sources, in other datasets has resulted in the self-citation rate for IJSEM in 2019 falling to less than 35% from a peak of over 40% (Figure 1). As both Scopus and the Leiden University CWTS database release their data earlier than the JCR, we had no reason to suspect levels of self-citation at the rate you claim.
Mellins-Cohen acknowledges that there were some suspect patterns:
Having said this, we did identify eight of the 817 groups who published with IJSEM in 2019, that had been artificially inflating their own citation rates via ‘salami slicing’. Despite this representing only 1% of publications in IJSEM, we have already put measures in place to prevent such activity and have applied those measures across the Microbiology Society portfolio. In fact, the current and previous Editors-in-Chief of IJSEM published an editorial calling on authors to avoid salami slicing in early 2018 (https://doi.org/10.1099/ijsem.0.002634) and early interventions to reduce such minimal publications were introduced then.
While the Microbiology Society is a signatory of the Declaration on Research Assessment, which eschews Impact Factors as a metric for quality, Mellins-Cohen quotes a member who writes:
Removing the Impact Factor of this well respected journal with a high standard of taxonomic descriptions will create confusion, as in some countries (China notably), it is requested to publish in journals with an Impact Factor only. The risk of the present situation is that scientists from these countries will no longer submit their articles to IJSEM and the quality of taxonomic descriptions may decrease, with a direct impact on patient management.
When we asked Clarivate for comment about Zootaxa’s appeal, a spokesperson told us:
We acknowledge that in exceptional circumstances there may be compelling editorial reasons for an atypical level of journal self-citation, which fulfils a genuine scholarly purpose. In such cases we will liaise with the publisher to resolve any appeal as we continue to improve our method of identifying and addressing citation distortion.
Like Retraction Watch? You can make a tax-deductible contribution to support our work, follow us on Twitter, like us on Facebook, add us to your RSS reader, or subscribe to our daily digest. If you find a retraction that’s not in our database, you can let us know here. For comments or feedback, email us at [email protected].
MDPI should be banned as well
@MDPI reviewer: why bring MDPI here? I did not see any mention of MDPI in this report. Please elaborate.
That’s so funny: “n such cases we will liaise with the publisher to resolve any appeal”
So if you want an impact factor, negotiate with Clarivate.
If you want a higher impact factor, also negotiate with Clarivate:
http://bjoern.brembs.net/2016/01/just-how-widespread-are-impact-factor-negotiations/
And Clarivate still pretends there are calculations going on in the background somewhere?
It must take some special form of gullibility to believe that.
The academicians should rely more on to the Scopus Cite score for journal impact which is more transparent and reliable and can track real time instead of doubtful impact factor.
Dear academicians
I think it is high time that a major overhaul of existing system is undertaken at international level for deciding impact factor . New Guidelines and regulations which are transparent needs to be articulated to the satisfaction of global academic community. Further all major countries must form a working group to address this issue.
From a concerned well wisher.
These organisations are like a monopoly deciding for so many academics on the quality of their articles. While it is stated that they work with certain criteria, who decided on them and why should we accept them? The amount of money that is paid to these organisations for journals and the publication is unacceptable, including the calculation of the impact factor. Yes, certainly an overhaul is required. After all these organisations would not exist if we did not publish our papers…maybe we should have a protest # denounce publication monopoly and impact factors…
Come on. 40%, 50%? Goodness, even 20% would be way too high! Are we trying to inbreed here or what? I stand with Clarivate Analystics on this one.
This is a decent, legit journal – the only one in a particular niche of psychology – and I am unsurprised there is a higher than usual level of self-citation as it has no direct competitor in terms of the subject area it covers. It’s not the highest impact journal I’ve published in by far, but it is the journal that I turn to the most when I need to find well-conducted research about body image! I’ve published here and been a peer reviewer for them for 8 years (rejected, and been rejected, plenty!). I’m currently nervously awaiting the decision for a paper I recently submitted to them. They are rigorous and impartial and I am pretty appalled by this decision. Authors don’t experience any pressure to cite articles from the journal. This suppression is depressing news for all of us that know and like the journal.
agree – everything is negotiable these days! interesting observation how one can appeal against the decision and get it reversed.
It’s funny when your PhD program requires a Q1 first-author paper to defend your PhD. You depend on the JCR for this, and you see the current JCR to choose your journal. You do your best, because you work in a small laboratory with a low budget and on top of that you work in basic science (which I love). In April you publish your article in a Q1 journal and you are happy because you finally meet the requirement of your doctoral program, which has cost you 3/4 years of your PhD!. But…in June the JCR come out and surprise! Clarivate has put your journal in “Journals Suppressed from 2019 JCR Data” by self-citation! And this is how your PhD depends on a company! Btw… does anyone know if Geroscience has claimed to Clarivate?